Sector Chart VYNE Therapeutics Inc.

Equities

VYNE

US92941V3087

Biotechnology & Medical Research

Delayed Nasdaq 02:22:01 2025-02-10 pm EST 5-day change 1st Jan Change
2.300 USD -4.56% Intraday chart for VYNE Therapeutics Inc. -1.51% -31.79%
"Total Return" performance includes dividend payments over the period, as if they were reinvested at 100%.
End-of-day quotes

Sector Bio Therapeutic Drugs

Capi. Sales growth Profitability Finances EV / Sales P/E ratio
35.55M - - -
121B -
75.99B
39.71B
28.2B -
23.85B -